Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A British Pharmacological Society Position Statement on Medications in Pregnancy and Lactation.

British journal of clinical pharmacology·2026
Same author

Which trial do we need? Treatment of severe measles.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Acceptability of a Dolutegravir Oral Dispersible Film in Term Neonates Born to Mothers Living With HIV.

Journal of the International AIDS Society·2026
Same author

Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

Open forum infectious diseases·2026
Same author

HIV broadly neutralizing antibodies for children: implementation barriers in low-income settings.

Current opinion in HIV and AIDS·2026
Same author

Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial.

EClinicalMedicine·2026

Related Experiment Video

Updated: Jun 9, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.5K

Optimising Paediatric HIV Treatment: Recent Developments and Future Directions.

Anne E M Kamphuis1, Alasdair Bamford2,3, Alfredo Tagarro4,5,6

  • 1Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. Anne.Kamphuis@radboudumc.nl.

Paediatric Drugs
|October 22, 2024
PubMed
Summary

New antiretroviral therapies are crucial for improving treatment outcomes in children with HIV, as current options show lower virological suppression rates. Concerted global efforts are needed to develop and implement effective pediatric HIV treatment strategies.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.8K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.3K

Related Experiment Videos

Last Updated: Jun 9, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.5K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.8K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.3K

Area of Science:

  • Pediatric Infectious Diseases
  • Antiretroviral Therapy Research
  • Global Health

Background:

  • Historically, pediatric HIV treatment lagged behind adult options in efficacy and practicality.
  • Despite progress, children with HIV generally have lower virological suppression rates than adults.
  • Challenges like adherence, toxicity, and resistance limit treatment success in some children.

Purpose of the Study:

  • To review current and emerging antiretroviral therapies for children living with HIV.
  • To highlight the need for new agents and innovative administration strategies.
  • To outline future directions for pediatric HIV treatment to meet global targets.

Main Methods:

  • This is a review article, synthesizing existing research and clinical data.
  • It analyzes the landscape of available and investigational pediatric antiretroviral formulations.
  • The review considers factors influencing treatment success and challenges in implementation.

Main Results:

  • Optimized pediatric antiretroviral formulations, including fixed-dose combinations, are increasingly available.
  • However, virological suppression rates in children remain suboptimal compared to adults.
  • New safe, effective, and well-tolerated agents and administration strategies are essential.

Conclusions:

  • Achieving 95% virological suppression in children requires a collaborative, multi-stakeholder approach.
  • Prioritizing drug development, accelerating regulatory processes, and facilitating implementation are key.
  • Continued innovation and global cooperation are vital for advancing pediatric HIV care.